Edwards Lifesciences Aktie
75,82
EUR
+0,98
EUR
+1,31
%
86,89
USD
+1,02
USD
+1,19
%
Edwards Lifesciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Edwards Lifesciences Aktie Analyse
| 06.02.07 | Edwards Lifesciences Market Perform | Piper Jaffray | |
| 06.02.07 | Edwards Lifesciences Sell | Goldman Sachs | |
| 30.12.05 | Edwards Lifesciences buy | Needham & Co | |
| 15.12.05 | Edwards Lifesciences buy | Needham & Co | |
| 14.12.05 | Edwards Lifesciences Buy | Needham & Co | |
| 09.12.05 | Edwards Lifesciences Overweight | Prudential Securities | |
| 25.07.05 | Edwards Lifesciences neutral | JP Morgan | |
| 22.07.05 | Edwards Lifesciences Neutral | JP Morgan | |
|
Werbung
|
|||
| 07.07.05 | Edwards Lifesciences Equal-weight | Morgan Stanley | |
| 14.06.05 | Edwards Lifesciences Underperform | First Albany | |
Werbung
Werbung